Advocacy intelligence hub — real-time data for patient organizations
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Available/year
Foundation grants
Copay cards
Travel grants
Foundation Grants3
Copay Assistance2
Patient Assistance Programs1
POMBILITI ATGA
AMICUS THERAPEUTICS US, LLC
Travel Grants8
Grant's Giants financial assistance
Grant’s Giants Pompe Awareness Nonprofit
PAN: Pompe Disease (Premium Assistance)
PAN: Pompe Disease Financial Assistance
Pompe Disease Financial Assistance Program
The Assistance Fund
Pompe Disease Financial Assistance Program - The Assistance Fund
Pompe disease medication copay assistance
PAN Foundation
Pompe disease medication copay assistance - PAN Foundation
PAN Foundation
The Assistance Fund: Pompe Disease
Lumizyme
(ALGLUCOSIDASE ALFA)Orphan drugGenzyme Corporation
Nexviazyme
(AVALGLUCOSIDASE ALFA-NGPT)Orphan drugGenzyme Corporation
POMBILITI ATGA
(CIPAGLUCOSIDASE ALFA-ATGA)Orphan drugAMICUS THERAPEUTICS US, LLC
Tippi C MacKenzie, MD
University of California, San Francisco
📍 San Francisco, California
Nicholas Johnson, MD
Virginia Commonwealth University
📍 Richmond, Virginia
Nathan Thibault, PharmD
Sanofi Global Medical Affairs Rare Diseases
📍 CAMBRIDGE, MA
Ans T van der Ploeg
From the University of Kansas Medical Center (M.M.D.
Priya S Kishnani
From the University of Kansas Medical Center (M.M.D.
📍 DURHAM, NC
Tahseen Mozaffar, MD
200 S. Manchester Avenue
📍 ORANGE, CA